Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T08:59:35.643Z Has data issue: false hasContentIssue false

Nosocomial Outbreak of Systemic Candidosis Associated With Parenteral Nutrition

Published online by Cambridge University Press:  21 June 2016

Maria Luisa Moro*
Affiliation:
Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanità Rome, Italy
Claudio Maffei
Affiliation:
Zstituto di Igiene, Università di Ancona
Esther Manso
Affiliation:
Zstituto di Igiene, Università di Ancona
Giulia Morace
Affiliation:
Zstituto di Microbiologia, Università Cattolica del Sacro Cuorer, Rome
Luciano Polonelli
Affiliation:
Zstituto di Microbiologia, Università Cattolica del Sacro Cuorer, Rome
Francesca Biavasco
Affiliation:
Istituto di Microbiologia, Universita di Ancona
*
Laboratorio di Epidemologia e Biostatistica, Istituto Superiors di Sanita, Viale Regina Elena, 299, 00161 Rome, Italy

Abstract

Eight patients in two surgical units developed systemic candidosis during a 40-day period from June 5 to July 13, 1987 (in five cases Candida albicans was identified). Three of them died. All cases belonged to a group of 27 patients receiving parenteral nutrition (PN), while among the 108 patients who did not receive PN, no cases were observed (p = .000001). Candida was cultured from two PN bags administered to the cases. A specialized nutrition nurse was responsible for the PN compounding and for maintaining administration sets in the two wards involved.

An epidemiological investigation in which 19 uninfected patients who had had PN were used as controls, showed no significant difference between cases and controls except that lipids were more frequently added to bags administered to cases (p = .0005). Furthermore, the bags administered to cases contained a higher average number of multidose constituents (p = .0008) when the comparison was focused on the two days before the onset of symptoms.Given the favorable medium provided by lipids, even a low level contamination of PN solutions during compounding and/or administration could have been responsible for the outbreak. The finding of a more frequent exposure of cases to multidose vials suggests, although not conclusively, that an extrinsic contamination occurred during compounding. Six isolates of C albicans were available from four cases. C albicans was cultured from the pharyngeal swabs of two physicians and three nurses, including the specialized nutrition nurse. According to DNA restriction pattern analysis, a single strain was responsible for all the cases of systemic candidosis, with only the specialized nutrition nurse harboring the same strain. DNA fingerprinting provided a reliable system for typing C albicans strains. This was the first outbreak of C albicans systemic infection associated with PN.

Type
Original articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control. Nosocomial Infection Surveillance, 1983. Atlanta, Georgia: CDC Surveillance Summaries No. 255: 1984.Google Scholar
2. Horn, R, Wong, B, Kiehn, TE, Armstrong, D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985;7:646655.10.1093/clinids/7.5.646CrossRefGoogle Scholar
3. McGowan, JE Jr. Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. Rev Infect Dis. 1985;7(suppl 3):357370.CrossRefGoogle ScholarPubMed
4. Morrison, AJ, Freer, CV, Searcy, MA, Landry, SM, Wenzel, RI? Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control. 1986;7:550553.CrossRefGoogle Scholar
5. Harvey, RL, Myers, JR Nosocomial fungemia in a large community teaching hospital. Arch Intern Med. 1987;147:21172120.10.1001/archinte.1987.00370120053011CrossRefGoogle Scholar
6. Edwards, JE Jr. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med. 1978;89:91106.CrossRefGoogle ScholarPubMed
7. Karabinis, A, Hill, C, Leclercq, B, Tancrède, C, Baume, D, Andremont, A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Mwrobiol. 1988;26:429432.10.1128/jcm.26.3.429-432.1988CrossRefGoogle ScholarPubMed
8. Plouffe, JF, Brown, DG, Silva, S, Terrence, E, Stricof, RL, Fekety, R Jr Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Intern Med. 1977;137:16861689.CrossRefGoogle ScholarPubMed
9. Solomon, SL, Khabbaz, RF, Parker, RH, et al. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis. 1984;149:98102.CrossRefGoogle ScholarPubMed
10. Burnie, JP, Odds, FC, Lee, W, Webster, C, Williams, JD. Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Brit Med J. 1985;290:746748.CrossRefGoogle ScholarPubMed
11. Burnie, JP, Matthews, R, Lee, W, et al. Four outbreaks of nosocomial systemic candidiasis. Epidem Inf. 1987;99:201211.10.1017/S0950268800067030CrossRefGoogle ScholarPubMed
12. Weems, JJ, Chamberland, ME, Ward, J, Willy, M, Padhye, AA, Solomon, SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol. 1987;25:10291032.CrossRefGoogle ScholarPubMed
13. Kaemmerer, D, Mayhall, CG, Hall, GO, Pesko, LJ, Thomas, RB. Microbial growth patterns in intravenous fat emulsions. Am J Hosp Pharm. 1983;40:16501653.Google Scholar
14. Kim, CH, Lewis, DE, Kumar, A. Bacterial and fungal growth in intravenous fat-emulsions. Am J Hosp Pharm. 1983;40:21592161.Google ScholarPubMed
15. Scherer, S, Stevens, DA. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol. 1987;125:675679.CrossRefGoogle Scholar
16. Phongpaichit, S, Mackenzie, DWR, Fraser, C. Strain differentiations of Candida albicans by morphotyping. Epidem Inf. 1987;99:421428.CrossRefGoogle Scholar
17. Polonelli, L, Archibusacci, L, Sestito, M, Morace, G. Killer system: a simple method for differentiating Candida albicans strains. J Clin Microbiol. 1983;17:774780.CrossRefGoogle ScholarPubMed
18. Morace, G, Archibusacci, C, Sestito, M, Polonelli, L. Strain differentiation of pathogenic yeasts by the killer system. Mycopathologia. 1984;84:8185.10.1007/BF00436517CrossRefGoogle ScholarPubMed
19. Norusis, MJ. SPSS/PC for the IBM PC/XT/AT. Chicago, Illinois: SPSS Inc.; 1986.Google Scholar
20. Maki, DG. Epidemic nosocomial bacteremias. In: Wenzel, RP, ed. Handbook of Hospital Acquired Infections. Boca Raton: CRC Press, 1981:371512.Google Scholar
21. Philips, I, Eykyn, S, Laker, M. Outbreak of hospital infection caused by contaminated autoclaved fluids. Lancet. 1972;1:12581260.CrossRefGoogle Scholar
22. Meers, PD. Calder, MW, Mazhar, MM, et al. Intravenous infusion of contaminated dextrose solution: the Devenport incident. Lancet. 1973;2:11891192.CrossRefGoogle Scholar
23. Maki, DG, Rhame, FS, Mackel, DC, et al. Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. Am J Med. 1976;60:471485.CrossRefGoogle ScholarPubMed
24. Matsanidis, NS, Vassiliki, S, Theodoridon, MC, Tzanetou, KG, Mostrou, GI. Enterobacter species in infants and children due to contaminated intravenous fluids. Infect Control. 1984;5:471477.10.1017/S0195941700060872CrossRefGoogle Scholar
25. Longfield, RN, Longfield, JN, Smith, LP, Hyams, KC, Strohmer, ME. Multi-dose medication vial sterility: an in-use study and a review of the literature. Infect Control. 1984;5:165169.10.1017/S0195941700059154CrossRefGoogle Scholar
26. Vaundry, WL, Tierner, AJ, Wenman, WM. Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis. 1988;158:13751379.10.1093/infdis/158.6.1375CrossRefGoogle Scholar
27. Matthews, R, Burnie, J. Assessment of DNA fingerprinting for rapid identification of outbreaks of systemic candidiasis. Br Med J. 1989;298:354357.10.1136/bmj.298.6670.354CrossRefGoogle ScholarPubMed
28. Hasenclever, HF, Mitchell, WO. Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans. J Bacteriol. 1961;82:570573.CrossRefGoogle ScholarPubMed
29. Odds, FC, Abbott, AB. A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species. Sabouraudia. 1980;18:301317.10.1080/00362178085380511CrossRefGoogle ScholarPubMed
30. Browne-Thomsen, J. Variability in Candida albicans (Robin) Berkhout. I. Studies on morphology and biochemical activity. Hereditas. 1968;60:675679.Google Scholar
31. Slutsky, B, Buffo, J, Soll, DR. High-frequency switching of colony morphology in Candida albicans. Science. 1985;230:666669.CrossRefGoogle ScholarPubMed
32. Soll, DR, Langtimm, CJ, McDowell, J Hicks, J, Galask, R. High-frequency switching in Candida strains isolated from vaginitis patients. J Clin Microbiol. 1987;25:16111622.10.1128/jcm.25.9.1611-1622.1987CrossRefGoogle ScholarPubMed
33. Williams, WW. Infection control during parenteral nutrition therapy. Journal of Parenteral and Enteral Nutrition. 1985;9:735746.CrossRefGoogle ScholarPubMed
34. Miller, PJ, Wenzel, RI. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis. 1987;156:471477.CrossRefGoogle ScholarPubMed
35. Wey, SB, Mori, M, Pfaller, MA, Woolson, RF, Wenzel, RI. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med. 1988;148:26422645.CrossRefGoogle ScholarPubMed